当前位置:
X-MOL 学术
›
Med. Chem. Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Indazole scaffold: a generalist for marketed and clinical drugs
Medicinal Chemistry Research ( IF 2.6 ) Pub Date : 2020-11-25 , DOI: 10.1007/s00044-020-02665-7 Yaquan Cao , Chunying Luo , Pu Yang , Pan Li , Chunli Wu
中文翻译:
吲唑支架:市售和临床药物的通才
更新日期:2020-11-25
Medicinal Chemistry Research ( IF 2.6 ) Pub Date : 2020-11-25 , DOI: 10.1007/s00044-020-02665-7 Yaquan Cao , Chunying Luo , Pu Yang , Pan Li , Chunli Wu
More and more attention has been paid to the structurally diverse indazole analogs in recent years which are widely present in numerous commercially available drugs. Indazole-containing derivatives are endowed with a broad range of biological properties, such as anti-inflammatory, antibacterial, anti-HIV, antiarrhythmics, antifungal and antitumor activities. This review is a guide for pharmacologists who are in search of valid preclinical/clinical drug compounds where the progress, from 1966 to the present day, of approved marketed drugs containing indazole scaffold is examined.
中文翻译:
吲唑支架:市售和临床药物的通才
近年来,结构多样化的吲唑类似物受到越来越多的关注,它们广泛存在于许多市售药物中。含吲唑的衍生物具有广泛的生物学特性,例如抗炎,抗菌,抗HIV,抗心律不齐,抗真菌和抗肿瘤活性。这篇综述为正在寻找有效的临床前/临床药物化合物的药理学家提供指南,该研究对1966年至今的批准的含吲唑支架的上市药物的进展进行了研究。